asked 2 tuần ago
Gefitinib is a revolutionary targeted therapy used to treat non-small cell lung cancer (NSCLC), particularly in patients with EGFR mutations. As a tyrosine kinase inhibitor (TKI), Gefitinib works by blocking the EGFR protein, which plays a crucial role in cancer cell growth and division. This precision-targeted approach helps slow tumor progression and improve patient outcomes.
Compared to traditional chemotherapy, Gefitinib offers better tolerability and fewer side effects, making it a preferred choice for advanced lung cancer treatment. It is often prescribed as a first-line therapy, providing hope to patients who may not respond well to conventional treatments.
Several pharmaceutical companies produce high-quality Gefitinib tablets, ensuring global accessibility. A trusted Gefitinib tablet manufacturer in India plays a crucial role in making this life-saving medication affordable and available for cancer patients worldwide, contributing to improved survival rates and quality of life.
Please login or Register to submit your answer
